4 main effects
Mechanism of Action
Enter neurons by competing for dopamine transporter, normally removes dopamine from cleft. Blocks vesicular monoamine transporter (VMAT), prevents dopamine from being stored in vesicles for release during a nerve impulse. Causes dopamine build up in neuron and flows into cleft in reverse, increases dopamine and norepinephrine at cleft
Short Term Effects
Euphoria, cardiovascular collapse possible, increased respiratory rate, insomnia, appetite suppression
Misuse Potential
Extremely high: orally, injected, smoked
Inherent Harmfulness: high, due to long-term toxicities
SUD potential
Tolerance: yes to euphoria + anorectic effects, no therapeutic effects
Withdrawal: yes: depression, sleep, hunger, fatigue
Addiction: yes: euphoria
Amphetamines
Synthetic organic compounds, structurally similar to neurotransmitters dopamine and norepinephrine, may contain side products (filler agents), harmful
Long Term Effects
Chronic sleeping problems, appetite supressant, psychoses/anxiety, mood swings, elevated bp and abnormal heart rhythm
Therapeutic Use
ADHD: improve attention and control
Narcolepsy
In Sports
increases endurance by 40%, speed 73%